CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 1774-1892 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T18","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T95964","span":{"begin":0,"end":118},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"SSI incidence rate increased from 0.91% [0.88-0.94%] for NNIS-0 patients to 13.8% [12.5−15.2%] for NNIS-2, 3 patients."}

    CORD-PICO

    {"project":"CORD-PICO","denotations":[{"id":"p1_all6","span":{"begin":0,"end":18},"obj":"Outcome"},{"id":"p2_i1","span":{"begin":57,"end":63},"obj":"Pharmacological"}],"text":"SSI incidence rate increased from 0.91% [0.88-0.94%] for NNIS-0 patients to 13.8% [12.5−15.2%] for NNIS-2, 3 patients."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T18","span":{"begin":0,"end":118},"obj":"Sentence"}],"text":"SSI incidence rate increased from 0.91% [0.88-0.94%] for NNIS-0 patients to 13.8% [12.5−15.2%] for NNIS-2, 3 patients."}